Arginine
5 organisations hold 5 active FDA Type IV Drug Master Files for Arginine. 5 valid EDQM Certificates of Suitability are on record for the same substance.
Sources: FDA List of Drug Master Files (checked 13 Nov 2026); FDA Global Substance Registration System (identity); EDQM Certification Online Database. Methodology
Active Type IV DMFs (5)
| Holder | DMF | Filed as | Submitted |
|---|---|---|---|
| CHANGZHOU SUNLIGHT PHARMACEUTICAL CO LTD | 44367 | ARGININE | Sept 2026 |
| HUBEI GEDIAN HUMANWELL PHARMACEUTICAL EXCIPIENTS CO LTD China | 42308 | ARGININE | Jul 2026 |
| SHANGHAI AJINOMOTO AMINO ACID CO LTD China | 39434 | L-ARGININE | Apr 2024 |
| AVT (SHANGHAI) PHARMACEUTICAL TECH CO LTD | 39677 | ARGININE | Apr 2024 |
| PFANSTIEHL INC United States | 38012 | L-ARGININE, HIGH PURITY, LOW ENDOTOXIN, LOW METALS, USP, EP, JP, CHP | Jan 2023 |
“Filed as” is the subject exactly as the holder gave it to the FDA, including the grade or pharmacopoeia it names. Holder names link to a company profile where one is published. An active filing can be referenced by a drug application; it is not proof of current supply.
Valid CEPs for this substance (5)
| Holder | Country | Certificate | Issued |
|---|---|---|---|
| AJINOMOTO CO INC | JP | CEP 1998-104 - Rev 05 Arginine | Aug 2026 |
| AJINOMOTO CO INC | JP | CEP 2022-190 - Rev 01 Arginine, SA | Aug 2026 |
| SHANGHAI PLUMINO AMINO ACID CO., LTD. Shanghai CN | CN | CEP 2010-045 - Rev 01 Arginine | Oct 2025 |
| AMINO GMBH | DE | CEP 2016-188 - Rev 01 Arginine | Sept 2025 |
| Kyowa Hakko Bio Co., Ltd. | JP | R1-CEP 1998-109 - Rev 05 Arginine | Mar 2022 |
Certification Online Database, European Directorate for the Quality of Medicines & HealthCare. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
What these records establish
- A Type IV DMF is a confidential file held by the FDA for an excipient, colourant or flavour. The FDA does not approve or disapprove it; it is reviewed when a drug application references it.
- Active means the file is open and can be referenced with the holder's letter of authorisation. It says nothing about price, capacity or current availability.
- The holder is the organisation that filed. It is usually, but not always, the manufacturer.
- Many excipients are supplied without any DMF, so this list is not every supplier of Arginine.
Do you supply Arginine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.